Serial Number | 98247335 |
Word Mark | BEACON THERAPEUTICS |
Filing Date | Monday, October 30, 2023 |
Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
Status Date | Monday, September 16, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 5 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
Published for Opposition Date | NOT AVAILABLE |
Description of Mark | The mark consists of the stylized blue text 'BEACON" above the stylized blue text "THERAPEUTICS". The letter "O" in the word "BEACONE" is replaced by a circle design made up of six inward-pointing blue triangles. |
Goods and Services | Pharmaceutical preparations and substances for the treatment of ocular disorders; biotechnological preparations for the treatment of ocular disorders; preparations for gene therapy and cell therapy for the treatment of ocular disorders; genetic medicines for the treatment of ocular disorders, all of foregoing available only by prescription from, and administration to patients by, clinical and medical professionals, and expressly excluding medical, devices, medical implants and medical apparatus and instruments of any kind |
Indication of Colors claimed | The color(s) blue is/are claimed as a feature of the mark. |
NOT AVAILABLE | "THERAPEUTICS" |
Goods and Services | Research and development services and clinical trials services in the fields of in relation to pharmaceutical preparations and substances for the treatment of disorders relating to the eye, biotechnological preparations for the treatment of disorders relating to the eye, preparations for gene therapy and cell therapy for the treatment of disorders relating to the eye and genetic medicines for the treatment of disorders relating to the eye; consulting services for others in the field of design planning and implementation project management of clinical trials in the fields of pharmaceutical preparations and substances for the treatment of disorders relating to the eye, biotechnological preparations for the treatment of disorders relating to the eye, preparations for gene therapy and cell therapy for the treatment of disorders relating to the eye and genetic medicines for the treatment of disorders relating to the eye; scientific research in the nature of conducting clinical trials for others in the fields of pharmaceutical preparations and substances for the treatment of disorders relating to the eye, biotechnological preparations for the treatment of disorders relating to the eye, preparations for gene therapy and cell therapy for the treatment of disorders relating to the eye and genetic medicines for the treatment of disorders relating to the eye |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, November 8, 2023 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, November 8, 2023 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Beacon Therapeutics Limited |
Party Type | 10 - Original Applicant |
Legal Entity Type | 24 - NOT AVAILABLE |
Address | London N79AS |
Event Date | Event Description |
Thursday, November 2, 2023 | NEW APPLICATION ENTERED |
Wednesday, November 8, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Tuesday, June 11, 2024 | ASSIGNED TO EXAMINER |
Saturday, June 15, 2024 | NON-FINAL ACTION E-MAILED |
Saturday, June 15, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Saturday, June 15, 2024 | NON-FINAL ACTION WRITTEN |
Monday, September 16, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Monday, September 16, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Monday, September 16, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |